The Discounted Cash Flow (DCF) valuation of Sarepta Therapeutics Inc (SRPT) is 39.81 USD. With the latest stock price at 18.24 USD, the upside of Sarepta Therapeutics Inc based on DCF is 118.2%.
Based on the latest price of 18.24 USD and our DCF valuation, Sarepta Therapeutics Inc (SRPT) is a buy. buying SRPT stocks now will result in a potential gain of 118.2%.
| Range | Selected | |
| WACC / Discount Rate | 7.6% - 10.5% | 9.1% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 25.05 - 81.67 | 39.81 |
| Upside | 37.4% - 347.7% | 118.2% |